Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Carcinoma, Squamous Cell × irinotecan sucrosofate × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Tumor-Agnostic 1

Conditions

Pancreatic Neoplasms 23 Colorectal Neoplasms 14 Small Cell Lung Carcinoma 6 Stomach Neoplasms 5 Neoplasms 4 Biliary Tract Neoplasms 4 Rectal Neoplasms 3 Neoplasm Metastasis 3 Sarcoma, Ewing 2 Rhabdomyosarcoma 2 Recurrence 2 Osteosarcoma 2 Nasopharyngeal Carcinoma 2 Glioma 2 Glioblastoma 2 Gastrointestinal Neoplasms 2 Cholangiocarcinoma 2 Wilms Tumor 1 Weight Loss 1 Triple Negative Breast Neoplasms 1 Somatostatinoma 1 Solid Tumor Cancer 1 Solid Tumor 1 Small Cell Lung Cancer Extensive Stage 1 Small Bowel Adenocarcinoma 1 Sarcoma 1 Rhabdoid Tumor 1 Pseudomyxoma Peritonei 1 Peritoneal Neoplasms 1 Pancreatic Cancer Metastatic to Liver 1

Interventions

Cisplatin 52 Radiotherapy 31 Carboplatin 23 Paclitaxel 22 Cetuximab 22 Radiotherapy, Intensity-Modulated 21 pembrolizumab 18 Docetaxel 17 Fluorouracil 16 Nivolumab 12 Drug Therapy 11 Radiation 9 Blood Specimen Collection 8 durvalumab 7 Erlotinib Hydrochloride 7 Surveys and Questionnaires 6 atezolizumab 5 Magnetic Resonance Spectroscopy 5 Esophagectomy 5 olaparib 4 dacomitinib 4 Surgical Procedures, Operative 4 Radiosurgery 4 Leucovorin 4 Chemoradiotherapy 4 Capecitabine 4 Biopsy 4 fludarabine phosphate 3 fludarabine 3 cemiplimab 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03719924 2025-01-08

OESIRI

Federation Francophone de Cancerologie Digestive

Phase 2 Completed

Carcinoma, Squamous Cell

Data powered by HemOnc (CC BY 4.0) Colophon ⚡